Download PDF
Z Gastroenterol 2014; 52(07): 746-748
DOI: 10.1055/s-0034-1366287
Kommentiertes Referat
© Georg Thieme Verlag KG Stuttgart · New York

Beginn einer neuen Ära in der Hepatitis-C-Therapie bei Patienten auf der Warteliste und nach Lebertransplantation

Begin of a New Era in Treating Hepatitis C in Patients on the Waiting List and after Liver Transplantation
S. K. Beckebaum
,
H. H.-J. Schmidt
Further Information

Publication History

Publication Date:
15 July 2014 (online)

Also available at
    Permissions and Reprints

Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, Lawitz E, Lok AS, Hinestrosa F, Thuluvath PJ, Schwartz H, Nelson DR, Everson GT, Eley T, Wind-Rotolo M, Huang S-P, Gao M, Hernandez D, McPhee F, Sherman D, Hindes R, Symonds W, Pasquinelli C, Grasela DM for the AI444 040 Study Group. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med 2014; 370 (3): 211 – 221.